文献速递乳腺乳腺X线

数字乳腺断层合成:技术、证据与临床实践更新

Digital Breast Tomosynthesis: Update on Technology, Evidence, and Clinical Practice.
PubMed 文献 · Radiographics · 2021-02-05

数字乳腺断层合成(DBT)已广泛用于乳腺癌筛查与诊断,较二维数字乳腺摄影(DM)优先提高浸润性癌检出而不增加原位癌检出,并降低筛查召回率、提高活检阳性率。DBT对结构扭曲敏感,尤其改善浸润性小叶癌的可见性;但在极度致密乳腺中获益有限,且是否降低乳腺癌特异性死亡率仍需进一步研究。

要点

  • DBT较DM优先提高浸润性癌检出,不增加原位癌检出,利于识别有生物学意义的病变。
  • DBT对结构扭曲更敏感,提高浸润性癌总体诊断并改善浸润性小叶癌可见性。
  • DBT降低筛查假阳性召回,提高诊断评估特异度及活检阳性率。

关键影像表现/征象

  • DBT较DM优先提高浸润性癌检出,而不增加原位癌检出。
  • DBT对结构扭曲的敏感度更高,提高浸润性癌总体诊断并尤其改善浸润性小叶癌的可见性。
  • DBT用于诊断性检查时提高活检阳性结果百分比。

临床应用与阅片要点

  • DBT较DM可降低筛查假阳性召回数量,提高诊断评估特异度。
  • DBT整合入诊断检查可提高活检阳性率,改善诊断信心。
  • 单次DBT阅片时间较DM长,但DBT简化诊断流程并减少短期随访检查需求,将时间资源重新分配至筛查。
  • 在极度致密乳腺女性中DBT的获益有限,且获益程度可能因实践环境和地理位置而异。
  • DBT对浸润性癌的增量检出低于超声和MRI。

局限性

  • 在极度致密乳腺女性中DBT的获益有限。
  • DBT的获益程度可能因实践环境和地理位置而异。
  • DBT对浸润性癌的增量检出低于超声和MRI。
  • 目前对DBT检出癌的生物学特征理解有限。
  • DBT是否改善乳腺癌特异性死亡率仍是关键问题,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Digital breast tomosynthesis (DBT) has been widely adopted in breast imaging in both screening and diagnostic settings. The benefits of DBT are well established. Compared with two-dimensional digital mammography (DM), DBT preferentially increases detection of invasive cancers without increased detection of in-situ cancers, maximizing identification of biologically significant disease, while mitigating overdiagnosis. The higher sensitivity of DBT for architectural distortion allows increased diagnosis of invasive cancers overall and particularly improves the visibility of invasive lobular cancers. Implementation of DBT has decreased the number of recalls for false-positive findings at screening, contributing to improved specificity at diagnostic evaluation. Integration of DBT in diagnostic examinations has also resulted in an increased percentage of biopsies with positive results, improving diagnostic confidence. Although individual DBT examinations have a longer interpretation time compared with that for DM, DBT has streamlined the diagnostic workflow and minimized the need for short-term follow-up examinations, redistributing much-needed time resources to screening. Yet DBT has limitations. Although improvements in cancer detection and recall rates are seen for patients in a large spectrum of age groups and breast density categories, these benefits are minimal in women with extremely dense breast tissue, and the extent of these benefits may vary by practice environment and by geographic location. Although DBT allows detection of more invasive cancers than does DM, its incremental yield is lower than that of US and MRI. Current understanding of the biologic profile of DBT-detected cancers is limited. Whether DBT improves breast cancer-specific mortality remains a key question that requires further investigation. ©RSNA, 2021.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Gao Y, Moy L, Heller SL, et al. Digital Breast Tomosynthesis: Update on Technology, Evidence, and Clinical Practice. Radiographics. 2021. PMID: 33544665. doi:10.1148/rg.2021200101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。